Now Recruiting for LightforPd Clinical Trial!
Know someone with Parkinson’s? If your loved one is managing PD, this could be the opportunity they’ve been hoping for. A new, at-home trial for PD is underway. No travel required.
Now Recruiting for LightforPd Clinical Trial!
Know someone with Parkinson’s? If your loved one is managing PD, this could be the opportunity they’ve been hoping for. A new, at-home trial for PD is underway. No travel required.
ADDRESSING MAJOR UNMET NEEDS
A Breakthrough Therapy for People Living with Parkinson’s Disease
Specialized phototherapy addresses both motor and non-motor symptoms
Over 11 million people worldwide live with Parkinson’s disease (PD), a number that is projected to double over the next 20 years. As with so many other neurodegenerative diseases, there have been no major breakthroughs in Parkinson’s disease in decades.
Our personalized at-home device promises to be one of the most significant therapeutic breakthroughs in Parkinson’s disease in decades. We have seen large improvements in our proof-of-concept studies – especially in addressing major unmet needs in Parkinson’s. We are initiating a pivotal trial of our key product, Celeste® specialized phototherapy, to confirm safety and sustained efficacy.
Despite the efficacy of dopaminergic drugs, people with PD continue to experience difficulties with unresolved motor symptoms and non-motor symptoms (e.g., sleep disorders, fatigue, and mood and cognitive problems). Impaired function significantly reduces quality of life for many, often preventing those living with PD from working, exercising, socializing, and doing the things they want to do.
We invite you to join us to improve the lives of individuals suffering from neurodegenerative diseases.
Seeing Specialized Phototherapy Clearly
Our non-invasive specialized phototherapy is well on its way to becoming a physician-prescribed standard of care.
When it comes to motor and non-motor symptoms of Parkinson’s, here’s what we’re seeing so far.
PROMISING RESULTS
and enjoyed improved quality of life.
NON-INVASIVE
LIFESTYLE FRIENDLY PROTOCOL
Trending Topics
PhotoPharmics Announces Leadership Transition in Clinical & Scientific Advisory Board
PhotoPharmics, a pioneer in specialized phototherapy for neurodegenerative diseases, today announced the appointment of Robert A. Hauser, MD, MBA, as the new Chairman of its Clinical & Scientific Advisory Board (CSAB). Dr. Hauser assumes this leadership role...
Understanding the Types of Parkinsonism
Introduction The tremor. The stiffness. The deliberate slowness of movement. These are the hallmarks often associated with Parkinson's disease. But what if these very same symptoms point to something else entirely? This is the complex reality of Parkinsonism....
Parkinson’s Iceberg: The Non-Motor Symptoms You Don’t See
Introduction “My father experienced hallucinations and delusions, and at the time, we didn't realize these symptoms were part of his Parkinson's disease. My mom tried to shield my family and carry the burden alone each day. I wish l'd known there was more to...
An Overview of Parkinson’s Disease
What is Parkinson’s? Parkinson’s Disease (PD) is a complex neurodegenerative disorder that affects the nervous system and progressively worsens over time. While motor symptoms—such as tremors, stiffness, and slow movement—are often the most observable and commonly...
PhotoPharmics to Present Patient Interest Findings from Groundbreaking Remote Parkinson’s Trial at PSG Annual Meeting
Presentation to Highlight Feasibility and Interest in Decentralized Home-Based Phase 3 Trial Salt Lake City, Utah — December 5, 2024 — PhotoPharmics, a pioneer in non-invasive phototherapy for neurological disorders, today announced it will present a poster titled “An...